John F. Fraser MBChB, PhD, MRCP, FRCA, FFARCSI, FCICM

John F. Fraser is Founder/Director of the Critical Care Research Group (CCRG), The Prince Charles Hospital & University of Queensland; Director of ICU St Andrew’s War Memorial Hospital; President Asia-Pac Extracorporeal Life Support Org; Founding member of the global clinical trials ECMOnet & CoChair Queensland Cardiovascular Research Network. Established in 2004, CCRG is Australia’s largest multi-disciplinary critical care research facility with 80+ world-leading clinicians, engineers, scientists, economists, and support staff from 6 continents. Under his leadership, CCRG has created 7 purpose-built biology, engineering, bio-fabrication labs and the largest preclinical ICU in the southern hemisphere.

John has 5 professorships with major Australian universities, published >550 peer-reviewed publications, received AUD41+million in competitive grants, delivered over 200 national and international keynotes and lectures, and is the senior editor of the most comprehensive textbook on Mechanical Circulatory Support. He has been awarded many international research awards, including the 2018 Australian Society of Medical Research Award. His multi-disciplinary research extends from basic science, preclinical, international clinical bionic heart and lung, sepsis, and respiratory support in resource-poor countries. He led Australia’s first-ever intentional NHMRC Centre for Research Excellence in Artificial Heart & Lungs.

In Jan 2020, Fraser co-founded the COVID-19 Critical Care Consortium with A/Prof G LiBassi and Dr. J Suen. The Consortium facilitated the collection of 35+million data points from ICU COVID-19 patients in 54 countries to aid intensivists to decide treatment pathways for the critically ill. With generous support from Bill and Melinda Gates Foundation and Minderoo, they developed dashboards with IBM. The Journal of the American Medical Association lauds the Consortium’s innovative global efforts as a quantum change in data collection in medical research.

Driven by a desire to translate great research into better clinical outcomes, Fraser co-founded BiVACOR with its inventor Dr. Dan Timms in 2007; and De Motu Cordis an award-winning med-tech startup to revolutionize emergency drug delivery. The company is chaired by John Eales, world-cup-winning Australian Wallabies Captain. The admission of his own father to ICU has encouraged him to work on improving patient-centered outcomes through the creation of 'ICU of the Future - the future of intensive care.